单核苷酸多态性阵列在检测骨髓增生异常综合征新的染色体病变方面补充了中期细胞遗传学。 - Suppr

Suppr

超能文献

Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS.

作者信息

Gondek L P, Tiu R, Haddad A S, O'Keefe C L, Sekeres M A, Theil K S, Maciejewski J P

出版信息

Leukemia. 2007 Sep;21(9):2058-61. doi: 10.1038/sj.leu.2404745. Epub 2007 May 24.

DOI:10.1038/sj.leu.2404745

PMID:17525728

Abstract

摘要

相似文献

Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS.单核苷酸多态性阵列在检测骨髓增生异常综合征新的染色体病变方面补充了中期细胞遗传学。

Leukemia. 2007 Sep;21(9):2058-61. doi: 10.1038/sj.leu.2404745. Epub 2007 May 24.

Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.在晚期和低危骨髓增生异常综合征中检测隐匿性染色体病变，包括获得性节段性单亲二体。

Exp Hematol. 2007 Nov;35(11):1728-38. doi: 10.1016/j.exphem.2007.08.009. Epub 2007 Oct 17.

Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.单核苷酸多态性阵列（SNP-A）通过中期细胞遗传学改善了骨髓增生异常综合征中染色体异常的识别。

J Clin Pathol. 2017 May;70(5):435-442. doi: 10.1136/jclinpath-2016-204023. Epub 2016 Nov 11.

Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.将中期细胞遗传学与单核苷酸多态性微阵列相结合，可以提高骨髓增生异常综合征的诊断产量，并更准确地识别预后。

Ann Med. 2022 Dec;54(1):2627-2636. doi: 10.1080/07853890.2022.2125173.

High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.高分辨率基因组阵列有助于检测骨髓增生异常综合征中新发的隐匿性染色体病变。

Exp Hematol. 2007 Feb;35(2):240-51. doi: 10.1016/j.exphem.2006.09.016.

Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.应用全基因组单核苷酸多态性微阵列分析对髓系恶性肿瘤 20q 染色体臂异常进行特征分析。

Genes Chromosomes Cancer. 2010 Apr;49(4):390-9. doi: 10.1002/gcc.20748.

Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.单核苷酸多态性微阵列核型分析：传统细胞遗传学检测失败的骨髓增生异常综合征的诊断和预后工具。

Genes Chromosomes Cancer. 2013 Dec;52(12):1167-77. doi: 10.1002/gcc.22112. Epub 2013 Oct 7.

Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.伴有5号染色体长臂缺失的骨髓增生异常综合征：细胞遗传学检测的指征与策略

Cancer Genet Cytogenet. 2008 Dec;187(2):101-11. doi: 10.1016/j.cancergencyto.2008.08.002.

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.SNP array 核型分析在骨髓增生异常综合征及相关髓系恶性肿瘤中的预后影响。

Blood. 2011 Apr 28;117(17):4552-60. doi: 10.1182/blood-2010-07-295857. Epub 2011 Feb 1.

[Progress of cytogenetic detection in myelodysplastic syndromes].[骨髓增生异常综合征的细胞遗传学检测进展]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1536-40.

引用本文的文献

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.一种用于定义骨髓增生性肿瘤中 TP53 突变临床意义的新方案。

J Hematol Oncol. 2023 Aug 3;16(1):91. doi: 10.1186/s13045-023-01480-y.

Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia.定义髓系肿瘤中TP53突变临床意义的新方案

Res Sq. 2023 Mar 9:rs.3.rs-2656206. doi: 10.21203/rs.3.rs-2656206/v1.

Ann Med. 2022 Dec;54(1):2627-2636. doi: 10.1080/07853890.2022.2125173.

Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.鉴定与骨髓增生异常综合征相关的潜在染色体异常。

Sci Rep. 2017 Sep 4;7(1):10354. doi: 10.1038/s41598-017-10551-3.

SNP Array in Hematopoietic Neoplasms: A Review.造血系统肿瘤中的单核苷酸多态性阵列：综述

Microarrays (Basel). 2015 Dec 22;5(1):1. doi: 10.3390/microarrays5010001.

Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.联合比较基因组杂交和单核苷酸多态性微阵列检测在骨髓增生异常综合征和意义未明的血细胞减少症中均存在隐匿性染色体病变。

Mod Pathol. 2016 Oct;29(10):1183-99. doi: 10.1038/modpathol.2016.104. Epub 2016 Jul 8.

Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.骨髓增生异常综合征的发病机制：疾病分子和非分子方面的概述

Blood Res. 2014 Dec;49(4):216-27. doi: 10.5045/br.2014.49.4.216. Epub 2014 Dec 23.

Molecular pathogenesis of myelodysplastic syndromes.骨髓增生异常综合征的分子发病机制

Transl Med UniSa. 2014 Feb 4;8:19-30. eCollection 2014 Jan.

Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine.基于 SNP 芯片的分子核型分析检测到的总基因组改变可预测接受阿扎胞苷治疗的 MDS 或 AML 患者的总生存期。

Blood Cancer J. 2013 Nov 1;3(11):e155. doi: 10.1038/bcj.2013.52.

The detection and implication of genome instability in cancer.癌症中基因组不稳定性的检测及其影响

Cancer Metastasis Rev. 2013 Dec;32(3-4):341-52. doi: 10.1007/s10555-013-9429-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验